PortfoliosLab logo

Adverum Biotechnologies, Inc. (ADVM)

Equity · Currency in USD · Last updated Mar 29, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Adverum Biotechnologies, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $286 for a total return of roughly -97.14%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%NovemberDecember2023FebruaryMarch
-97.14%
105.69%
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADVM

Adverum Biotechnologies, Inc.

Return

Adverum Biotechnologies, Inc. had a return of 37.93% year-to-date (YTD) and -45.58% in the last 12 months. Over the past 10 years, Adverum Biotechnologies, Inc. had an annualized return of -33.71%, while the S&P 500 had an annualized return of 8.70%, indicating that Adverum Biotechnologies, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month14.29%0.03%
Year-To-Date37.93%3.43%
6 months-13.04%8.65%
1 year-45.58%-12.59%
5 years (annualized)-32.40%8.81%
10 years (annualized)-33.71%8.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202312.24%10.60%
2022-18.10%-8.95%-22.54%-13.43%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adverum Biotechnologies, Inc. Sharpe ratio is -0.70. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.70
-0.54
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Dividend History


Adverum Biotechnologies, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-98.67%
-17.21%
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Adverum Biotechnologies, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adverum Biotechnologies, Inc. is 99.10%, recorded on Dec 27, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.1%Jan 8, 20152007Dec 27, 2022
-19.26%Aug 1, 20143Aug 5, 20149Aug 18, 201412
-17.74%Sep 30, 20149Oct 10, 201417Nov 4, 201426
-12.89%Sep 15, 20145Sep 19, 20145Sep 26, 201410
-10.31%Nov 5, 201411Nov 19, 20144Nov 25, 201415
-8.51%Dec 23, 20142Dec 24, 20142Dec 29, 20144
-8.47%Jan 6, 20151Jan 6, 20151Jan 7, 20152
-7.31%Aug 21, 20144Aug 26, 201411Sep 11, 201415
-5.55%Nov 28, 20142Dec 1, 20142Dec 3, 20144
-3.38%Dec 31, 20141Dec 31, 20141Jan 2, 20152

Volatility Chart

Current Adverum Biotechnologies, Inc. volatility is 87.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2023FebruaryMarch
87.51%
17.27%
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)